Skip to main content
SpringerLink
Log in

Autologous hematopoietic stem cell transplantation following pulsed cyclophosphamide in a severely disabled patient with malignant multiple sclerosis

  • Letter to the Editors
  • Published:
Journal of Neurology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Capello E, Mancardi GL (2004) Marburg type and Balò’s concentric sclerosis: rare and acute variants of multiple sclerosis. Neurol Sci 25(Suppl 4):S361–S363

    Article  PubMed  Google Scholar 

  2. Reston JT, Uhl S, Treadwell JR, Nash RA, Schoelles K (2011) Autologous hematopoietic cell transplantation for multiple sclerosis: a systematic review. Mult Scler 17:204–213

    Article  PubMed  Google Scholar 

  3. Fagius J, Lundgren J, Oberg G (2009) Early highly aggressive MS successfully treated by hematopoietic stem cell transplantation. Mult Scler 15:229–237

    Article  PubMed  CAS  Google Scholar 

  4. Snowden JA, Saccardi R, Allez M, Ardizzone S, Arnold R, Cervera R, Denton C, Hawkey C, Labopin M, Mancardi G, Martin R, Moore JJ, Passweg J, Peters C, Rabusin M, Rovira M, van Laar JM, Farge D (2012) Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 47:770–790

    Article  PubMed  CAS  Google Scholar 

  5. Mancardi GL, Murialdo A, Rossi P, Gualandi F, Martino G, Marmont A, Ciceri F, Schenone A, Parodi RC, Capello E, Comi G, Uccelli A (2005) Autologous stem cell transplantation as rescue therapy in malignant forms of multiple sclerosis. Mult Scler 11:367–371

    Article  PubMed  Google Scholar 

  6. Burt RK, Balabanov R, Voltarelli J, Barreira A, Burman J (2012) Autologous hematopoietic stem cell transplantation for multiple sclerosis–if confused or hesitant, remember: ‘treat with standard immune suppressive drugs and if no inflammation, no response’. Mult Scler 18:772–775

    Article  PubMed  Google Scholar 

  7. Burt RK, Loh Y, Cohen B, Stefoski D, Stefosky D, Balabanov R, Katsamakis G, Oyama Y, Russell EJ, Stern J, Muraro P, Rose J, Testori A, Bucha J, Jovanovic B, Milanetti F, Storek J, Voltarelli JC, Burns WH (2009) Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study. Lancet Neurol 8:244–253

    Article  PubMed  CAS  Google Scholar 

  8. Le Bouc R, Zéphir H, Majed B, Vérier A, Marcel M, Vermersch P (2012) No increase in cancer incidence detected after cyclophosphamide in a French cohort of patients with progressive multiple sclerosis. Mult Scler 18:55–63

    Article  PubMed  Google Scholar 

  9. Gauthier SA, Weiner HL (2005) Cyclophosphamide therapy for MS. Int MS J 12:52–58

    PubMed  CAS  Google Scholar 

  10. Saccardi R, Freedman MS, Sormani MP, Atkins H, Farge D, Griffith LM, Kraft G, Mancardi GL, Nash R, Pasquini M, Martin R, Muraro PA, Group EBaMT, Research CfIBaM, Group HiMIS (2012) A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper. Mult Scler 18:825–834

    Article  PubMed  CAS  Google Scholar 

Download references

Conflicts of interest

None to declare.

Ethical standard

Informed consent for publication was obtained from the patient.

Author information

Authors and Affiliations

  1. Sheffield Institute for Translational Neuroscience, University of Sheffield, 385A Glossop Road, Sheffield, S10 2HQ, UK

    James J. P. Alix, Daniel J. Blackburn & Basil Sharrack

  2. Department of Clinical Neurology, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Trust, Sheffield, UK

    James J. P. Alix, Daniel J. Blackburn, Dilraj Sokhi & Basil Sharrack

  3. Department of Radiology, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Trust, Sheffield, UK

    Ian Craven

  4. Department of Haematology, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Trust, Sheffield, UK

    John A. Snowden

Authors
  1. James J. P. Alix
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daniel J. Blackburn
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dilraj Sokhi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ian Craven
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Basil Sharrack
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. John A. Snowden
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to James J. P. Alix.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Alix, J.J.P., Blackburn, D.J., Sokhi, D. et al. Autologous hematopoietic stem cell transplantation following pulsed cyclophosphamide in a severely disabled patient with malignant multiple sclerosis. J Neurol 260, 914–916 (2013). https://doi.org/10.1007/s00415-012-6796-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-012-6796-8

Keywords

Search

Navigation